Conclusions To summarize, this secondary analysis of a randomized clinical trial examined changes in site-specific BMD during diet-induced weight loss followed by a 1-year intervention with liraglutide (3.0 mg/day), exercise, or their combination, compared to placebo
Flow cytometry analysis Cells for apoptosis analysis by flow cytometry were seeded in six-well plates at a density of 3 10 5 per well (in triplicate) and cultured for 24 h
Functional Functional Always active The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network
Less common but important side effects Some side effects warrant closer attention: Hair loss
While semaglutide and tirzepatide are currently FDAapproved options within this category, additional peptide therapies such as retatrutide are in advanced clinical trials
Consult medical professionals and legal experts when in doubt about medication or health risks
